Celularity Inc 8-K

What Happened

• On July 23, 2026, Celularity Inc. (NASDAQ: CELU) received a notice from Nasdaq’s Listing Qualifications department that it no longer meets the minimum bid price requirement under Nasdaq Listing Rule 5450(a)(1). Nasdaq determined the company’s Class A common stock closed below $1.00 per share for 30 consecutive business days.
• The notice does not remove the company’s listing immediately; the Company has a 180-calendar-day compliance period (until January 19, 2027) to regain a closing bid price of at least $1.00 per share for a minimum of 10 consecutive business days. The stock continues to trade on the Nasdaq Capital Market under the symbol “CELU.”

Key Details

• Notice date: July 23, 2026.
• Cause: closing bid price below $1.00 for 30 consecutive business days (Nasdaq Rule 5450(a)(1)).
• Cure period: 180 calendar days, expiring January 19, 2027; require $1.00+ close for 10 consecutive business days to regain compliance.
• Possible extension: if other initial listing standards (except bid price) are met, the Company may be eligible for an additional 180-day grace period.

Why It Matters

• This notice signals a risk of delisting if Celularity’s stock price does not recover to meet Nasdaq’s bid-price standard within the cure period. Delisting proceedings could reduce liquidity and make trading more difficult for shareholders.
• The Company said it will monitor the stock price and evaluate options to regain compliance, but there is no guarantee it will succeed or obtain an extension. Investors should watch for updates from the company and consider the increased potential for share-price volatility until compliance is regained.